Results 271 to 280 of about 50,472 (297)

Neoadjuvant durvalumab with or without stereotactic body radiotherapy in patients with early-stage non-small-cell lung cancer: a single-centre, randomised phase 2 trial

Lancet Oncology, The, 2021
Nasser K Altorki, Olivier Elemento, Timothy E Mcgraw   +2 more
exaly  

Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised, phase 3, non-inferiority trial

Lancet Oncology, The, 2022
Andrew Loblaw, Suneil Jain, Philip Camilleri   +2 more
exaly  

Stereotactic body radiotherapy treatment of extracranial metastases

Nature Reviews Clinical Oncology, 2012
Fang-Fang Yin
exaly  

Stereotactic Body Radiotherapy

2018
openaire   +2 more sources

Radiotherapy (stereotactic body radiotherapy) for oligometastatic disease

2022
Paula Peleteiro Higuero, Patricia Calvo Crespo, Ana María Carballo Castro   +2 more
openaire   +1 more source

Radiotherapy combination opportunities leveraging immunity for the next oncology practice

Ca-A Cancer Journal for Clinicians, 2017
Fernanda G Herrera, Jean Bourhis, George Coukos   +2 more
exaly  

Liver Stereotactic Body Radiotherapy (SBRT)

2022
Olwen Leaman Alcibar, Fernando López Campos, José Antonio Blanco, Patricia Tavera Pomata, Carmen Rubio   +4 more
openaire   +1 more source

Immunotherapy and stereotactic ablative radiotherapy (ISABR): a curative approach?

Nature Reviews Clinical Oncology, 2016
Sunil Krishnan, James W Hodge
exaly  

Radiotherapy for brain tumors

Ca-A Cancer Journal for Clinicians, 1994
Normand J Laperriere, Mark Bernstein
exaly  

Stereotactic Body Radiotherapy

2020
Hoogeman, M.S. (Mischa), Granton, P. (Patrick), Milder, M.T.W. (Maaike), Heijmen, B.J.M. (Ben), Chen, Hanbo   +4 more
openaire   +1 more source